Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experience

Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experience
Front Neurosci. 2021 Mar 19;15:653377. doi: 10.3389/fnins.2021.653377. eCollection 2021.ABSTRACTThe international Linked Clinical Trials (iLCT) program for Parkinson's to date represents one of the most comprehensive drug repurposing programs focused on one disease. Since initial planning in 2010, it has rapidly grown - giving rise to seven completed, and 15 ongoing, clinical trials of 16 agents each aimed at delivering disease ... read more
Source: PubMedPublished on 2021-04-05By Simon R W Stott